Key result
Intravenous adenosine reverted supraventricular tachycardia to stable sinus rhythm in 75% of treated episodes, requiring a mean effective dose of /kg.
Why the study?
Does intravenous adenosine effectively revert supraventricular tachycardia in pediatric patients in the emergency department?
Observational (n=26)
No
Does intravenous adenosine effectively revert supraventricular tachycardia in pediatric patients in the emergency department?
Pediatric patients with SVT often require multiple and higher doses of adenosine than typically recommended in guidelines to achieve normal sinus rhythm.
Answers are grounded in this paper and cite their sources.
Adenosine may support SVT reversion in pediatric emergencies; hypothesis-generating and requires prospective trials before practice change.
OBJECTIVE: Supraventricular tachycardia (SVT) is the most frequent arrhythmia requiring treatment in childhood, with an estimated incidence of 1/100 to 1/250 children. The treatment of choice of the acute event is intravenous adenosine. This study aimed to determine if doses of adenosine higher than previously described are needed to successfully revert SVT in children. METHODS: This is a retrospective study of SVT cases in a tertiary hospital from January 2007 to December 2011. RESULTS: A total of 44 episodes of SVT were recorded in 26 patients. Mean age was 3.1 years. In 39 patients (89%), adenosine was administered, reverting to stable sinus rhythm in 29 episodes, which represents an effectiveness of 75%. In relation to the number of doses administered, 12 patients (30%) received a single dose, with a mean (SD) response dose of 112 (35) µg/kg; 16 (41%) received 2 doses, with a mean (SD) response dose of 188 (55) µg/kg; and 9 (24%) received 3 doses, with a mean (SD) response dose of 249 (108) µg/kg. Finally, in 2 patients (4%), 4 doses of adenosine were administered, with only 1 of them responding to a dose of 300 µg/kg. The mean (SD) dose that reverted the SVT to normal sinus rhythm was 173 (84) µg/kg, and the mean (SD) number of doses administered was 1.7 (0.8) (range, 1-4). Sixty-six percent were discharged home, without the need to be transferred to pediatric intensive care unit or pediatric ward. CONCLUSIONS: Most of the patients with SVT episodes require treatment with more than 1 dose of adenosine. Doses higher than the usually described in the guidelines are necessary to revert SVT. Most patients can be discharged home from the emergency department, without the need of hospital admission.
No takes yet. Share an insight, caveat, or question.
Díaz-Parra et al. (2014) conducted an observational in Supraventricular tachycardia (SVT) (n=26). Adenosine was evaluated on Reversion to stable sinus rhythm. Intravenous adenosine reverted supraventricular tachycardia to stable sinus rhythm in 75% of treated episodes, requiring a mean effective dose of /kg.
Synapse has enriched 10 related papers. Consider them for comparative context: